
University of Bristol biotech spin-out CytoSeek has raised £1.1m to help develop new cell therapies to treat cancer. The firm, based at Bristol’s Unit DX science incubator, has created cell membrane augmentation technology that could lead to new ways of tackling cancer. The process involves modifying a patient’s own...